AD obserwacje kliniczne 6. Papierska L, Rabijewski M. Bisfosfo- niany w leczeniu osteoporozy – za- lecenia a rzeczywistość, Forum Med Rodz 2010; 4(6): 423-430. 7. Varun B, Sivakumar T, Nair BJ, Jo- seph AP. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review, J Oral Maxillofac Pathol 2012 May; 16(2): 210-214. 8. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced ava- scular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg. 2003 Sep; 61(9): 1115-7. 9. Leśniak W, Chloupek A, Biernacka B, Przybysz J, Piętka T, Domański W, Dąbrowski J, Krzymański G. Martwica kości szczęk związana ze stosowa- niem bifosfonianów, opis przypad- ków, Pediatr Med Rodz 2013; 9(2): 197-200. 10. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Ma- xillofacial Surgeons Position Paper on Bisphosphonate-Related Osteone- crosis of the Jaw – 2009 Update, Aust Endod J. 2009 Dec; 35(3): 119-130. 11. Pelaz A, Junquera L, Gallego L, Gar- cía-Consuegra L, García-Martínez L, Cutilli T, Olay S. Epidemiology, Phar- macology and Clinical Characterization of Bisphosphonate-related Osteone- crosis of the Jaw. A Retrospective Stu- dy of 70 Cases, Acta Otorhinolaringol Esp 2015 May-Jun; 66(3): 139-147. 12. Kolur T, Nair SC, Kumar B. Oste- onecrosis of Maxilla Secondary to Bisphosphonate Therapy: A Case Re- port, J Maxillofac Oral Surg 2015 Mar; 14(Suppl 1): 52-56. 13. Salvatore L, Ruggiero SL, Fantasia J, Carlson E. Bisphophonates related osteonecrosis of the jaws, Oral Surg Oral Med Oral Pathol Oral Radiol En- dod 2006 Oct; 102(4): 433-441. 14. Gavaldá C, Bagán JV. Concept, dia- gnosis and classification of bispho- sphonate associated osteonecrosis of the jaws. A review of the literature, Med Oral Patol Oral Cir Buccal 2016 May; 21(3): 260-270. 15. Montefusco V, Gay F, Spina F, Miceli R, Maniezzo M, Teresa Ambrosini M, Fari- na L, Piva S, Palumbo A, Boccadoro M, Corradini P. Antibiotic prophylaxis befo- re dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates, Leuk Lympho- ma 2008 Nov; 49(11): 2156-2162. 16. Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA. Updated recommendations for managing the care of patients rece- iving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scien- tific Affairs, J Am Dent Assoc 2008 Dec; 139(12): 1674-1677. 17. Iglesias-Linares A, Yáñez-Vico RM, Solano-Reina E, Torres-Lagares D, González Moles MA. Influence of bi- sphosphonates in orthodontic thera- py: Systematic review, J Dent 2010 Aug; 38(8): 603-611. 18. CHMP assessment report on bispho- sphonates and osteonecrosis of the jaw, European Medicines Agency, London 2009. 19. Frank S, Fiołna K, Wojtowicz A. Mar- twica kości szczęk w wyniku stosowa- nia bisfosfonianów. Przegląd piśmien- nictwa, Dental Forum 2013; 2(41). 20. Hoefert S, Eufinger H. Relevance of a prolonged preoperative antibiotic regime in the treatment of bispho- sphonate-related osteonecrosis of the jaw, J Oral Maxillofac Surg 2011 Feb; 69(2): 362-380. 21. Bermúdez-Bejarano EB, Serrera-Fi- gallo MA, Gutiérrez-Corrales A, Ro- mero-Ruiz MM, Castillo-de-Oyagüe R, Gutiérrez-Pérez JL, Torres-Lagares D. Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bi- sphospho-nates, J Clin Exp Dent 2017 Jan; 9(1): 141-149. 22. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth extrac- tion in patients taking intravenous bisphosphonates: a preventive proto- col and case series, J Oral Maxillofac Surg 2010 Jan; 68(1): 107-110. 23. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth extrac- tion in patients taking intravenous bisphosphonates: a preventive proto- col and case series. J Oral Maxillofac Surg. 2010;68:107-10. implants 2 2018 31